Eagle Pharmaceuticals gets 180 days marketing exclusivity for Endo’s Vasostrict generic
- BySeeking Alpha-
Eagle Pharmaceuticals received 180 days of marketing exclusivity from the the U.S
Symbol | Exchange | Currency |
|---|
Eagle Pharmaceuticals received 180 days of marketing exclusivity from the the U.S
Zacks Investment Research upgraded shares of Eagle Pharmaceuticals (NASDAQ:EGRX) from a hold rating to a buy rating in a report issued on Thursday morning, Zacks.com reports. They...
Eagle Pharmaceuticals (NASDAQ:EGRX) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Thursday, Zacks.com...
Teva Pharmaceutical Industries Limited (NYSE:TEVA) reported fourth-quarter 2019 earnings of 62 cents per share, which came in line with the Zacks Consensus Estimate. Earnings per...
Tyme Technologies, Inc. (NASDAQ:TYME) announced that it has dosed the first patient in part 2 of the pivotal study — TYME-88-Panc — evaluating lead cancer...
Shares of Tyme Technologies, Inc. (NASDAQ:TYME) rise 13% after itannounced a collaboration with Eagle Pharmaceuticals Inc. (NASDAQ:EGRX) to co-promote the investigational...
Eagle Pharmaceuticals, Inc. is an integrated pharmaceutical company. The Company takes a molecule from preclinical research through regulatory approval and into the marketplace, including development, manufacturing and commercialization. The Company identifies challenging-to-treat diseases of the central nervous system or metabolic critical care therapeutic areas, as well as in oncology. The Company offers three products: Ryanodex, dantrolene sodium) (Ryanodex), bendamustine ready-to-dilute (RTD) 500ml solution (Belrapzo), and rapidly infused bendamustine RTD (Bendeka). The Company market Ryanodex and Belrapzo, and Teva Pharmaceutical Industries Ltd. (Teva) markets Bendeka a lyophilized powder formulation of bendamustine hydrochloride in Japan.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Sell | Sell | Strong Sell | Strong Sell |
| Technical Indicators | Sell | Strong Buy | Strong Sell | Strong Sell | Neutral |
| Summary | Neutral | Neutral | Strong Sell | Strong Sell | Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 169.80 | 172.54 | 169.40 | -3.27 | -1.89% | 90.23M | NASDAQ | |||
| 2,719.96 | 2,742.63 | 2,708.76 | -69.65 | -2.50% | 1.70M | NASDAQ | |||
| 318.15 | 324.21 | 317.64 | -13.75 | -4.14% | 22.20M | NASDAQ | |||
| 54.11 | 54.55 | 53.43 | -0.84 | -1.53% | 31.88M | NYSE | |||
| 1,030.51 | 1,070.79 | 1,016.06 | -19.10 | -1.82% | 21.69M | NASDAQ | |||
| 3,178.35 | 3,194.69 | 3,153.29 | -64.41 | -1.99% | 3.24M | NASDAQ | |||
| 18.56 | 18.84 | 18.47 | -0.12 | -0.64% | 12.94M | NYSE | |||
| 108.91 | 113.75 | 104.40 | -7.74 | -6.64% | 3.73M | NYSE | |||
| 10.54 | 10.96 | 10.44 | -0.17 | -1.54% | 5.44M | NYSE | |||
| 5.48 | 5.62 | 5.42 | -0.110 | -1.97% | 20.98M | NYSE | |||
| 69.75 | 71.39 | 69.64 | -1.75 | -2.45% | 4.18M | NYSE | |||
| 28.60 | 29.24 | 28.33 | +0.37 | +1.31% | 11.32M | NYSE | |||
| 18.82 | 19.89 | 17.80 | -1.75 | -8.51% | 55.42M | NYSE | |||
| 1.25 | 1.34 | 1.24 | -0.1100 | -8.09% | 11.87M | NYSE | |||
| 256.48 | 257.10 | 254.31 | -1.23 | -0.48% | 2.86M | NYSE |